Kenji M Fujihara (Kenji Fujihara)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Venues

Cell death & disease

NPJ breast cancer

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Peter MacCallum Cancer Centre (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Peter MacCallum Cancer Centre

Australia

PHD :: Division of Cancer Research

University of Melbourne

Australia

BSC :: Medicine, Dentistry & Health Sciences

Publications

Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, Nicholas James Clemons, Kenji M Fujihara, Thomas Riseborough, Amina Teunisse, Aart G Jochemsen, Lars Abrahmsén, Giovanni Blandino, Andrea Russo, Cristina Gamell, Stephen B Fox, Catherine Mitchell, Elena A Takano, David J Byrne, Panimaya Jeffreena Miranda, Reem Saleh, Heather Thorne, Shahneen Sandhu, Scott G Williams, Simon P Keam, Ygal Haupt, Sue Haupt
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status. Cancers 14 (16) (2022)
Thomas D Jackson, Jordan James Crameri, Linden S Muellner-Wong, Ann E Frazier, Catherine S Palmer, Luke E Formosa, Daniella H Hock, Kenji M Fujihara, Tegan Stait, Alice J Sharpe, David R Thorburn, Michael T Ryan, David Arthur Stroud, Diana Stojanovski
Sideroflexin 4 is a complex I assembly factor that interacts with the MCIA complex and is required for the assembly of the ND2 module. Proceedings of the National Academy of Sciences of the United States of America 119 (13) (2022)
Sophia Ceder, Sofi E Eriksson, Ying Yu Liang, Emarndeena H Cheteh, Si Min Zhang, Kenji M Fujihara, Julie Bianchi, Vladimir J N Bykov, Lars Abrahmsen, Nicholas James Clemons, Pär Nordlund, Sean G Rudd, Klas G Wiman
Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells. Cell death & disease 13 (8) (2022)
Kenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, Moses Olalekan Ogunkola, Brunda Nijagal, Julia V Milne, David A Sallman, Ching-Seng Ang, Iva Nikolic, Conor J Kearney, Simon J Hogg, Carlos S Cabalag, Vivien R Sutton, Sally Watt, Asuka T Fujihara, Joseph A Trapani, Kaylene J Simpson, Diana Stojanovski, Silke Leimkühler, Sue Haupt, Wayne A Phillips, Nicholas James Clemons
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Science advances 8 (37) (2022)
Kenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, Bonnie Z Zhang, Hyun Soo Ko, David S Liu, Kaylene J Simpson, Ygal Haupt, Lara Lipton, Sue Haupt, Wayne A Phillips, Nicholas James Clemons
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status. Molecular cancer therapeutics 20 (10) (2021)
Sophia Ceder, Sofi E Eriksson, Ying Yu Liang, Emarndeena H Cheteh, Si Min Zhang, Kenji M Fujihara, Julie Bianchi, Vladimir J N Bykov, Lars Abrahmsen, Nicholas James Clemons, Pär Nordlund, Sean G Rudd, Klas G Wiman
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells. Cell death & disease 12 (7) (2021)
Sophia Ceder, Sofi E Eriksson, Emarndeena H Cheteh, Swati Dawar, Mariana Corrales Benitez, Vladimir J N Bykov, Kenji M Fujihara, Mélodie Grandin, Xiaodun Li, Susanne Ramm, Corina Behrenbruch, Kaylene J Simpson, Frédéric Hollande, Lars Abrahmsen, Nicholas James Clemons, Klas G Wiman
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death. EMBO molecular medicine 13 (2) (2020)
Dane Cheasley, Lisa Devereux, Siobhan Hughes, Carolyn Nickson, Pietro Procopio, Grant Lee, Na Li, Vicki Pridmore, Kenneth Elder, G Bruce Mann, Tanjina Kader, Simone M Rowley, Stephen B Fox, David J Byrne, Hugo Saunders, Kenji M Fujihara, Belle Lim, Kylie L Gorringe, Ian G Campbell
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density. NPJ breast cancer 6 (2020)

Kenji M Fujihara.css-eqlu8i{font-size:small;padding-left:4px;} (Kenji Fujihara)

Publication Activity (10 Years)

Top Topics

Top Venues

Kenji M Fujihara (Kenji Fujihara)